Inceptive CEO Jakob Uszkoreit on Designing Medicines That Work Like Life Itself
CEO & Founder Conversations
•
21m
Inceptive CEO Jakob Uszkoreit goes Inside the ICE House to challenge the foundational assumptions of modern drug discovery, arguing that AI will enable medicines that work with the body's natural complexity rather than against it. He discusses Inceptive's partnership with Alnylam Pharmaceuticals and why their RNA interference platform and rich data history make them a uniquely powerful AI collaborator. Uszkoreit explains why partnerships are essential for a small company with broadly applicable technology, and why the long-term prize is therapies that are gentler, earlier, and truly personalized.
Up Next in CEO & Founder Conversations
-
Formation Bio CEO Ben Liu on Fixing t...
Formation Bio is rewriting the rules of drug development at a time when AI is accelerating drug discovery far faster than the industry can bring new therapies to patients. CEO Ben Liu goes Inside the ICE House to explain why the real bottleneck in pharma isn't finding promising drug candidates, i...
-
Geordie CEO Henry Comfort + Balderton...
Geordie CEO Henry Comfort + Balderton Capital Partner James Wise joins Kristen Scholer on NYSE Floor Talk
-
Camp Commerce: Former Jones Road CEO ...
Former Jones Road CEO Cody Plofker hoins Ashley Mastronardi on NYSE Floor Talk
